Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management

  • R. Torta | riccardo.torta@unito.it Clinical and Oncological Psychology Unit, University of Turin, Italy.
  • F. Pennazio Clinical and Oncological Psychology Unit, University of Turin, Italy.
  • V. Ieraci Clinical and Oncological Psychology Unit, University of Turin, Italy.

Abstract

The high prevalence of emotional disorders (anxiety, chronic stress, mood depression) in patients with pain during rheumatologic diseases (particularly fibromyalgia) is closely related to the common pathogenic mechanisms concerning emotions and pain. Therefore a prompt identification of any psychic component of pain, also by means of specific tools, is a must, because it can require an adjustment of the therapeutic approach by combining both an analgesic treatment and antidepressants and/or psychotherapeutic strategies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2014-06-06
Info
Issue
Section
Reviews
Keywords:
Emotional disorders, Antidepressants, Psychotherapeutic strategies.
Statistics
  • Abstract views: 1396

  • PDF: 863
How to Cite
Torta, R., Pennazio, F., & Ieraci, V. (2014). Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management. Reumatismo, 66(1), 92-97. https://doi.org/10.4081/reumatismo.2014.769